Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewSB 706504 is a p38 MAPK inhibitor. Inhibits LPS-induced transcription of a range of chemokines and cytokines in chronic obstructive pulmonary disease (COPD) monocyte derived macrophages (MDMs). Also inhibits LPS-induced protein expression of IL-6, IL-10, TNFα and γ-inducible protein 10 in COPD MDMs. Effects on suppression of LPS-induced gene and protein expression are enhanced in combination with dexamethasone (Cat. No. 1126).
Sold for research purposes under agreement from GlaxoSmithKline
SB 706504 is also offered as part of the Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.
M. Wt | 492.46 |
Formula | C24H19F3N8O |
Storage | Desiccate at RT |
Purity | ≥98% (HPLC) |
CAS Number | 911110-38-8 |
PubChem ID | 11853799 |
InChI Key | ZQFBVJBAWLZLOM-UHFFFAOYSA-N |
Smiles | N=C(NC#N)NCCNC1=NC(C4=C(C)C=C(F)C=C4)=C(C=CC(N2C3=C(F)C=CC=C3F)=O)C2=N1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 49.25 | 100 |
The following data is based on the product molecular weight 492.46. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.03 mL | 10.15 mL | 20.31 mL |
5 mM | 0.41 mL | 2.03 mL | 4.06 mL |
10 mM | 0.2 mL | 1.02 mL | 2.03 mL |
50 mM | 0.04 mL | 0.2 mL | 0.41 mL |
References are publications that support the biological activity of the product.
Kent et al (2009) Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexameth. and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl) J.Pharmacol.Exp.Ther. 328 458 PMID: 19004925
If you know of a relevant reference for SB 706504, please let us know.
Keywords: SB 706504, SB 706504 supplier, SB706504, p38, MAPK, inhibitors, map, kinases, inhibits, dexamethasone, inflammatory, cytokines, 5040, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for SB 706504. Do you know of a great paper that uses SB 706504 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review SB 706504 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
MAP kinase signaling is integral to the regulation of numerous cellular processes such as proliferation and differentiation, and as a result is an important focus of cancer and immunology research. Updated for 2016, this review discusses the regulation of the MAPK pathway and properties of MAPK cascades. Compounds available from Tocris are listed.